Heparin-induced thrombocytopenia among patients of a comprehensive cancer center

Most clinical studies of heparin-induced thrombocytopenia have not included cancer patients who have high risk of thromboembolism, frequent exposure to heparin, and many potential causes of thrombocytopenia other than heparin-induced thrombocytopenia. To estimate the incidence and prevalence of hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Weixin, Merriman, Kelly, Nabaah, Amr, Seval, Nikhil, Afshar-Kharghan, Vahid, Yeung, Sai-Ching J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857356/
https://www.ncbi.nlm.nih.gov/pubmed/27489647
http://dx.doi.org/10.1177/2050313X14533945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857356/
https://www.ncbi.nlm.nih.gov/pubmed/27489647
http://dx.doi.org/10.1177/2050313X14533945

Ejemplares similares